- Home
- INCR vs PMVP Comparison
INCR vs PMVP Comparison
Compare INCR & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- PMVP
- Stock Information
- Founded
- INCR 1994
- PMVP 2013
- Country
- INCR Israel
- PMVP United States
- Employees
- INCR N/A
- PMVP N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- INCR Health Care
- PMVP Health Care
- Exchange
- INCR Nasdaq
- PMVP Nasdaq
- Market Cap
- INCR 76.7M
- PMVP 71.9M
- IPO Year
- INCR N/A
- PMVP 2020
- Fundamental
- Price
- INCR $1.38
- PMVP $1.02
- Analyst Decision
- INCR
- PMVP Strong Buy
- Analyst Count
- INCR 0
- PMVP 3
- Target Price
- INCR N/A
- PMVP $5.33
- AVG Volume (30 Days)
- INCR 10.9K
- PMVP 103.3K
- Earning Date
- INCR 04-08-2025
- PMVP 03-03-2025
- Dividend Yield
- INCR N/A
- PMVP N/A
- EPS Growth
- INCR N/A
- PMVP N/A
- EPS
- INCR N/A
- PMVP N/A
- Revenue
- INCR $72,420,918.00
- PMVP N/A
- Revenue This Year
- INCR N/A
- PMVP N/A
- Revenue Next Year
- INCR $39.30
- PMVP N/A
- P/E Ratio
- INCR N/A
- PMVP N/A
- Revenue Growth
- INCR N/A
- PMVP N/A
- 52 Week Low
- INCR $1.17
- PMVP $0.96
- 52 Week High
- INCR $3.72
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- INCR 28.88
- PMVP 20.23
- Support Level
- INCR $1.36
- PMVP $1.21
- Resistance Level
- INCR $1.49
- PMVP $1.18
- Average True Range (ATR)
- INCR 0.06
- PMVP 0.06
- MACD
- INCR -0.01
- PMVP -0.02
- Stochastic Oscillator
- INCR 4.67
- PMVP 0.00
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.